[1] Jemal A, Bray F, Center MM, et al.Global Cancer Statistics[J]. Ca-Cancer J Clin, 2011, 61(2): 69-90.
[2] Covacci A, Telford JL, Del Giudice G, et al.Helicobacter pylori virulence and genetic geography[J]. Science, 1999, 284(5418): 1328-1333.
[3] Hunt RH, Xiao SD, Megraud F, et al.Helicobacter pylori in Developing Countries. World Gastroenterology Organisation Global Guideline[J]. J Gastrointest Liver, 2011, 20(3): 299-304.
[4] McColl KEL. Helicobacter pylori Infection[J]. New Engl J Med, 2010, 362(17): 1597-1604.
[5] Fock KM.Review article: the epidemiology and prevention of gastric cancer[J]. Aliment Pharm Therap, 2014, 40(3):250-260.
[6] Go MF.Review article: natural history and epidemiology of Helicobacter pylori injection[J]. Aliment Pharm Therap, 2002, 16: 3-15.
[7] Ishaq S, Nunn L.Helicobacter pylori and gastric cancer: a state of the art review[J]. GastroenterolHepatol Bed Bench, 2015, 8(Suppl 1): S6-S14.
[8] Asaka M, Mabe K, Matsushima R, et al.Helicobacter pylori Eradication to Eliminate Gastric Cancer: The Japanese Strategy[J]. GastroenterolClin N, 2015, 44(3): 639-648.
[9] Herrero R, Park JY, Forman D.The fight against gastric cancer - the IARC Working Group report[J]. Best Pract Res Cl Ga, 2014, 28(6): 1107-1114.
[10] Moss SF.The Clinical Evidence Linking Helicobacter pylori to Gastric Cancer[J]. Cell MolGastroenter, 2017, 3(2): 183-191. |
